Folate-decorated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting delivery: optimization and in vivo antitumor activity

References

• Danhier F, Kouhé TTB, Duhem N, et al. (2014). Vitamin E-based micelles enhance the anticancer activity of doxorubicin. Int J Pharm 476:9–15
   PubMed Web of Science ®Google Scholar
• Forrest RA, Swift LP, Rephaeli A, et al. (2012). Activation of DNA damage response pathways as a consequence of anthracycline–DNA adduct formation. Biochem Pharmacol 83:1602–12
   PubMed Web of Science ®Google Scholar
• Joo SY, Kim JS. (2002). Enhancement of gene transfer to cervical cancer cells using transferrin-conjugated liposome. Drug Dev Ind Pharm 28:1023–31
   PubMed Web of Science ®Google Scholar
• Joseph MM, Aravind SR, George SK, et al. (2015). Anticancer activity of galactoxyloglucan polysaccharide-conjugated doxorubicin nanoparticles: mechanistic insights and interactome analysis. Eur J Pharm Biopharm 93:183–95
   PubMed Web of Science ®Google Scholar
• Kim JH, Sung NY, Raghavendran HB, et al. (2009). Gamma irradiation reduces the immunological toxicity of doxorubicin, anticancer drug. Radiat Phys Chem 78:425–8
   Web of Science ®Google Scholar
• Meng H, Xue M, Xia T, et al. (2011). Use of size and a copolymer design feature to improve the biodistribution and the enhanced permeability and retention effect of doxorubicin-loaded mesoporous silica nanoparticles in a murine xenograft tumor model. ACS Nano 5:4131–44
   PubMed Web of Science ®Google Scholar
• Ruan S, Cao X, Cun X, et al. (2015). Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release. Biomaterials 60:100–10
   PubMed Web of Science ®Google Scholar
• Sadighian S, Rostamizadeh K, Hosseini-Monfared H, et al. (2014). Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery. Colloids Surf B 117:406–13
   PubMed Web of Science ®Google Scholar
• Song D, Li H, Li H, et al. (2015). Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer (Review). Oncol Lett 10:600–6
   PubMed Web of Science ®Google Scholar
• Tan EC, Lin R, Wang CH. (2005). Fabrication of double-walled microspheres for the sustained release of doxorubicin. J Colloid Interface Sci 291:135–43
   PubMed Web of Science ®Google Scholar
• Wei LJ, Marasini N, Li G, et al. (2012). Development of ligustrazine-loaded lipid emulsion: formulation optimization, characterization and biodistribution. Int J Pharm 437:203–12
   PubMed Web of Science ®Google Scholar
• Wu Y, Lu CT, Li WF, et al. (2013). Preparation and antitumor activity of bFGF-mediated active targeting doxorubicin microbubbles. Drug Dev Ind Pharm 39:1712–19
   PubMed Web of Science ®Google Scholar
• Yang Y, Li N, Nie Y, et al. (2015). Folate-modified poly (malic acid) graft polymeric nanoparticles for targeted delivery of doxorubicin: synthesis, characterization and folate receptor expressed cell specificity. J Biomed Nanotechnol 11:1628–39
   PubMed Web of Science ®Google Scholar
• Yi X, Bekeredjian R, DeFilippis NJ, et al. (2006). Transcriptional analysis of doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 290:H1098–102
   PubMed Web of Science ®Google Scholar
• Yoo HS, Park TG. (2004). Folate receptor targeted biodegradable polymeric doxorubicin micelles. J Control Release 96:273–83
   PubMed Web of Science ®Google Scholar
• Yuan F, Qin X, Zhou D, et al. (2008). In vitro cytotoxicity, in vivo biodistribution and antitumor activity of HPMA copolymer-5-fluorouracil conjugates. Eur J Pharm Biopharm 70:770–6
   PubMed Web of Science ®Google Scholar
• Zhang HJ, Chen BA, Jiang H, et al. (2011). A strategy for ZnO nanorod mediated multi-mode cancer treatment. Biomaterials 32:1906–14
   PubMed Web of Science ®Google Scholar
• Zhang C, Dong YF, Zhao LQ. (2013). Preparation and characterization of novel microparticles based on poly(3-hydroxybutyrate-co-3-hydroxyoctanoate). J Microencapsul 31:9–15
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lee SH, Feng SS. (2007). Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 28:1889–99
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhao LQ, Dong YF, et al. (2010). Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery. Eur J Pharm Biopharm 76:10–16
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Dai DD, Lu CT, et al. (2012). Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in vitro and in vivo. Drug Dev Ind Pharm 38:1090–8
   PubMed Web of Science ®Google Scholar
• Zhao LQ, Xiao JF, Feng T, et al. (2006). Synthesis of poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) by a Sinorhizobium fredii strain. Lett Appl Microbiol 42:344–9
   PubMed Web of Science ®Google Scholar